Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples